- Medical - Distribution
- Healthcare
-
3.01
EPS
-
21.21
P/E
-
8.19B
MARKET CAP
-
0.00%
DIV YIELD
Company Overview
135 DURYEA RD,MELVILLE NY 11747,6318435500
CEO
Mr. Stanley M. Bergman
Employess
25000
Sector
Healthcare
Industry
Medical - Distribution
Website
https://www.henryschein.com
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Next Earnings Date
Nov. 11, 2024
Ex Dividends date
--
Dividend Date
--
YTD Performance
-15.40%
Fiscal Year End
12-25
IPO Date
1995-11-03
Growth Rates
(avg. rate of change) | 10 years | 5 years | 3 years | 1 year |
---|---|---|---|---|
Sales/Revenue | 2.58% | -1.34% | 6.83% | -2.44% |
EPS | 2.39% | -1.96% | 4.09% | -19.49% |
Equity | 2.76% | 4.30% | 2.97% | 6.07% |
Cash | -0.98% | 16.35% | -25.95% | 46.15% |
Return On Capital (ROIC) | 12.28% | 11.68% | 11.56% | 9.14% |
Debt
year (millions) | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Short Term Debt | 494 | 182 | 138 | 248 | 199 |
Long Term Debt | 1,930 | 1,320 | 1,080 | 754 | 799 |
LT Finance Leases | 314 | 348 | 344 | 303 | 242 |
Shares Outstanding | 131 | 136 | 140 | 143 | 148 |
Market Cap | 9,890 | 10,900 | 10,500 | 9,380 | 9,840 |
Price
News
Henry Schein, Inc. (HSIC) Q2 2024 Earnings Call Transcript
1 monthHenry Schein, Inc. (NASDAQ:HSIC ) Q2 2024 Earnings Conference Call August 6, 2024 10:00 AM ET Company Participants Graham Stanley - VP, IR & Strategic Financial Project Officer Stanley Bergman - Chairman & CEO Ronald South - SVP and CFO Conference Call Participants Jon Block - Stifel Jason Bednar - Piper Sandler Elizabeth Anderson - Evercore ISI John Stansel - JPMorgan Dane Reinhardt - Baird Operator Good morning, ladies and gentlemen, and welcome to Henry Schein's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded.
seekingalpha.comCompared to Estimates, Henry Schein (HSIC) Q2 Earnings: A Look at Key Metrics
1 monthWhile the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zacks.comHenry Schein (HSIC) Q2 Earnings Surpass, 2024 Guidance Slashed
1 monthHenry Schein's (HSIC) second-quarter results reflect an improvement in sales trends in distribution businesses.
zacks.comHenry Schein (HSIC) Q2 Earnings Beat Estimates
1 monthHenry Schein (HSIC) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.31 per share a year ago.
zacks.comHenry Schein cuts annual profit forecast as cyberattack impact lingers
1 monthHenry Schein lowered its annual profit forecast on Tuesday as the dental and medical equipment distributor warned of a slower recovery from a cyberattack that was disclosed by the company in October last year.
reuters.comThe Zacks Analyst Blog Baxter International, Henry Schein and IDEXX Laboratories
1 monthBaxter International, Henry Schein and IDEXX Laboratories are included in this Analyst Blog.
zacks.comWhat's in Store for These 3 MedTech Stocks in Q2 Earnings?
1 monthMedTech companies' quarterly results are likely to be strong on a sequential basis. Let's see how BAX, HSIC and IDXX are placed ahead of their earnings releases.
zacks.comCountdown to Henry Schein (HSIC) Q2 Earnings: Wall Street Forecasts for Key Metrics
1 monthEvaluate the expected performance of Henry Schein (HSIC) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
zacks.comHenry Schein Details Progress in 2023 CARES Report on Sustainability and Corporate Citizenship
2 monthsMELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today released its 2023 CARES Report on Sustainability and Corporate Citizenship. Henry Schein Cares, our global corporate citizenship program, aims to drive positive change through its five pillars: Catalyzing health care access; Advancing policies, solutions and innovation; Relationship-building for change; Empowering Team.
businesswire.comEarnings Preview: Henry Schein (HSIC) Q2 Earnings Expected to Decline
2 monthsHenry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.comHere's Why Henry Schein (HSIC) is a Strong Momentum Stock
2 monthsWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.comHow to Play Henry Schein (HSIC) Ahead of Q2 Earnings?
2 monthsHenry Schein (HSIC) is expected to deliver impressive sales in both its businesses in the second quarter of 2024, along with a steady pace of recovery from the cyber incident.
zacks.com